Pfizer, BioNTech seek first vaccine approval in US

The BioNTech/Pfizer shot is one of two vaccines that have taken the lead in the global race for inoculation against Covid-19. – EPA pic, November 21, 2020.

US biotech giant Pfizer and German partner BioNTech sought approval yesterday to roll out their coronavirus vaccine early, a first step towards relief as surging infections prompt a return to shutdowns that traumatised nations and the global economy earlier this year.

The world is looking to scientists for salvation from the global pandemic, as a new wave of infections forces New York to shut schools and California to implement night time curfews.

Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!

Sign up or sign in here to comment.